Filter
10889
Filtered Results: 10889
Text search:
patients
Featured
Recommendations
1064
New Publications
2539
Language
Document type
No document type
5816
Guidelines
1617
Studies & Reports
1550
Manuals
533
Fact sheets
399
Strategic & Response Plan
318
Training Material
210
Situation Updates
138
Resource Platforms
86
Infographics
76
Brochures
57
Online Courses
52
Videos
32
App
4
Dashboards/Maps
1
Countries / Regions
India
493
Global
374
South Africa
264
Kenya
246
Sierra Leone
237
Liberia
227
Western and Central Europe
212
Congo, Democratic Republic of
203
Nigeria
179
Ethiopia
175
Africa
174
Uganda
171
Germany
157
Senegal
155
Latin America and the Carribbean
143
Rwanda
132
Malawi
127
Tanzania
126
Nepal
123
Guinea
122
Burkina Faso
116
Russia
114
Syria
110
Zambia
107
Ukraine
106
Bangladesh
100
Myanmar / Burma
100
Ghana
99
West and Central Africa
96
Eastern Europe
89
Haiti
85
Brazil
81
Namibia
72
Philippines
69
East and Southern Africa
68
Mozambique
67
Middle East and North Africa
67
Indonesia
66
Mali
63
Benin
63
Cameroon
61
South Sudan
56
Cambodia
54
South–East Asia Region
54
Lesotho
51
Asia
51
Côte d’Ivoire / Ivory Coast
50
Zimbabwe
50
Venezuela
47
Madagascar
44
Yemen
40
Eastern Europe and Central Asia
40
Colombia
34
Botswana
34
Central African Republic
31
Peru
28
Eswatini/ Swaziland
27
Angola
27
USA
26
Chad
26
Argentina
26
Niger
25
Ecuador
21
Paraguay
21
Chile
20
Western Pacific Region
19
Guinea-Bissau
17
Togo
16
Pakistan
16
Tajikistan
15
Spain
15
Somalia
14
Iraq
14
Sudan
14
Bolivia
14
Vietnam
14
Afghanistan
13
Thailand
12
Albania
12
Lebanon
11
China
11
Georgia
11
Jordan
10
El Salvador
10
Sri Lanka
10
Laos
10
United Kingdom
10
Palestine
9
Southern Africa
9
Moldova
9
North America
9
Burundi
8
Mexico
8
France
8
Switzerland
7
Armenia
7
Saudi Arabia
6
Turkey
6
North Macedonia
6
Morocco
5
Egypt
5
Ireland
5
Papua New Guinea
5
Bhutan
5
Canada
5
Kazakhstan
5
Jamaica
5
Gambia
4
Hungary
4
Honduras
4
Greece
4
Libya
4
Poland
4
Congo-Brazzaville
4
Romania
4
Iran
4
Uzbekistan
4
Kyrgyzstan
4
Singapore
3
Austria
3
Serbia
3
Guatemala
3
Italy
3
Timor Leste/ East Timor
3
Estonia
3
Mauritius
3
Portugal
3
Malaysia
2
Nicaragua
2
Other region
2
Fiji
2
Bulgaria
2
Lithuania
2
Slovakia
2
Australia
2
Gabon
2
Uruguay
2
Belgium
2
Tunisia
2
Belarus
2
Mauritania
1
Luxembourg
1
Solomon Islands
1
North Korea
1
Djibouti
1
Mongolia
1
Qatar
1
Turkmenistan
1
Japan
1
Denmark
1
Maldives
1
Norway
1
South Korea
1
Algeria
1
French Guyana
1
Israel
1
Latvia
1
United Arab Emirates
1
Authors & Publishers
Publication Years
Category
Countries
3933
Clinical Guidelines
969
Public Health
559
Women & Child Health
393
Key Resources
338
Capacity Building
239
Pharmacy & Technologies
128
Annual Report MEDBOX
2
Toolboxes
COVID-19
1408
Mental Health
856
TB
727
HIV
718
Ebola
592
Caregiver
434
AMR
374
Rapid Response
361
NTDs
315
NCDs
287
Refugee
275
Pharmacy
223
Conflict
214
Disability
198
Planetary Health
163
Global Health Education
108
Cholera
101
Zika
84
Natural Hazards
77
Specific Hazards
63
Polio
54
Health Financing Toolbox
44
Social Ethics
42
Typhoon
3
South Sudan
1
Health Financing
1
Around the world, nurses are working under enormous pressure providing care to sick and dying patients during the pandemic. Many are faced with increased stress, and other negative effects on their mental health. They are also faced with the possibi...
Consistent, current and complete documentation in the medical record is an essential component of quality patient care. The following 21 elements reflect a set of commonly accepted standards for medical record documentation. An organization may use ...
This collection of posters are intended for health care workers, biomedical engineers and staff of health facilities in charge of caring, cleaning, decontaminating and sterilizing respiratory medical equipment in hospitals and health facilities. They include checklists to ensure the optimal infectio...
This collection of posters are intended for health care workers, biomedical engineers and staff of health facilities in charge of caring, cleaning, decontaminating and sterilizing respiratory medical equipment in hospitals and health facilities. They include checklists to ensure the optimal infectio...
tep 1 Competencies have been designed to provide staff with the core skills required to care for a critically ill patient safely, whilst under supervision. It is expected that Step 1 competencies will be completed prior to commencing an academic cri...
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
w...
Bilevel or two-level Positive Airway Pressure (BiPAP).
Continuous Positive Airway Pressure (CPAP)
During non-invasive ventilation and between patients
Always read and follow the instructions and recommendations of the manufacturer`s manual
Con...
The guide is suitable and can be used for the following audiences:
1. nurses and other trained healthcare workers who can use this manual as a self-study tool and then incorporate its guidance into their practice;
2. governmental and non-governmental employers of lay and professional TB treatment ...
The WHO Trauma Bag 2021 is intended to provide the resources needed to care for care of acutely ill and injured patients in hospital emergency units, field hospitals or clinics providing acute care. The Trauma Bag may also be applicable in prehospi...
SAFER Ukraine is a humanitarian effort launched following the Russian invasion to provide safe passage for childhood cancer patients and their families out of Ukraine.
The Protection of Personal Information (POPI) Act
Confidentiality: providing and protecting information
• Health care practitioners hold information about patients that is private and sensitive.
• The National Health Act (Act No. 61 of 2003) ...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate t...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate t...
Note technique. Les centres de traitement de choléra fournissent des soins hospitaliers aux patients atteints de choléra
pendant les épidémies. Une prise en charge de qualité et l’isolement des pa... atteints du choléra sont
essentiels pour prévenir les décès et aider à lutter contre la propagation de la maladie. Traditionnellement,
ces structures sont appelées centres de traitement du choléra (CTC) et unités de traitement du choléra (UTC).
Les CTC sont généralement de grandes structures mises en place au niveau central (zones urbaines, par
exemple), tandis que les UTC sont des structures plus petites, installées en périphérie (zones périurbaines ou
rurales, par exemple). Les CTC/UTC peuvent être mis en place en tant que structures indépendantes dans
des tentes ou à l’intérieur de bâtiments existants ou dans des unités sanitaires. Quelle que soit la structure,
les principes décrits dans ce document doivent être respectés.
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Centra...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The ...-centred platform aims to facilitate clinical research, provide a forum for technical discussions, develop a critical mass of expertise, and strengthen institutional research capacities. In addition, it identifies and reviews priority needs, works towards standardization of methodology to assess drug efficacy and reviews alternatives for using current approved drugs (new schemes, doses, combination) and special scenarios (resistance).
At the forefront of DNDi’s efforts to develop new treatments is the need to understand the realities and treatment needs of patients and health care staff in the field. The ultimate goal for human African trypanosomiasis (HAT) is a truly simplifie...
Le présent manuel a pour but de fournir des orientations concernant la conception,
l’organisation et l’évaluation d’un cours visant à établir et à renforcer les capacités des
personnels de santé pour qu’ils puissent prendre en charge les p... ophtalmiques dans
les établissements de soins de santé primaires dans la Région africaine. Le cours s’inscrit dans
le cadre du perfectionnement professionnel continu au sens le plus large du terme. Son
contenu met l’accent sur des pratiques simples fondées sur des données factuelles que l’on
peut facilement appliquer dans des établissements de soins de santé primaires partout en
Afrique.
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in ... with non-severe COVID-19
The guidance includes updated risk rates for hospital admission in patients with non-severe COVID-19.
The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients.
This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines:
**High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%.
**Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%.
Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk.
Review of COVID-19 treatments for people with non-severe COVID-19
WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022.
If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead.
WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission.
For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol.
WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials.
The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials.
